A U.S. Appeals Court ruled on December 1, 2025, that New York Attorney General Letitia James cannot prevent pro-life pregnancy centers from promoting abortion pill reversal (APR), upholding a preliminary injunction on free speech grounds. The decision protects the centers’ First and Fourteenth Amendment rights to share religiously and morally motivated information about using progesterone to counteract the effects of mifepristone, the first pill in a chemical abortion regimen. This victory blocks James’s attempts to silence life-affirming options for women regretting their abortion decisions. The case stemmed from James’s lawsuit against nearly a dozen crisis pregnancy centers, accusing them of misleading women under consumer protection laws by touting APR as effective.
Represented by the Thomas More Society and Alliance Defending Freedom (ADF), the centers argued that such restrictions violate constitutional protections. ADF Senior Counsel Caleb Dalton praised the ruling, highlighting that women have successfully saved their babies through APR, emphasizing the importance of access to this potentially life-saving information. The three-judge panel affirmed the lower court’s injunction, rejecting James’s appeal and allowing the centers to continue discussing safe and effective progesterone treatments for reversal if the second abortion pill, misoprostol, has not been taken.
The court stressed that the centers’ speech is protected, countering efforts to censor pro-life advocacy. This follows James’s pattern of targeting pro-lifers, including a 2023 injunction against Red Rose Rescues and an unsuccessful 2024 bid to move related litigation. Abortion pill reversal addresses the dangers of chemical abortions, where mifepristone blocks progesterone needed for pregnancy, and misoprostol expels the baby. Pro-life advocates note that APR can intervene effectively in time, saving lives amid rising at-home abortion risks, as evidenced by a Canadian woman’s near-death experience from pill complications.